IMERYS (EPA:NK) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
IMERYS

BRIEF

published on 11/12/2024 at 17:50, 8 days 20 hours ago

Imerys Reports Share Capital and Voting Rights Update

Share Capital Voting Rights Financial Disclosure Imerys Mineral Solutions
REGULATED PRESS RELEASE

published on 11/12/2024 at 17:45, 8 days 20 hours ago

imerys-12-November-2024-information-share-capital-and-voting-rights-as-of-31-October-2024
Imerys discloses the number of outstanding shares and voting rights as of 31 October 2024, complying with French regulations. The leading global supplier of mineral-based solutions reported €3.8B revenue in 2023, offering solutions to various industries

Voting Rights Revenue Outstanding Shares Imerys Mineral-Based Solutions
BRIEF

published on 11/06/2024 at 08:10, 15 days 5 hours ago

Imerys Moves Forward in US Talc-Related Litigation

Imerys Chapter 11 Talc Litigation Plan Of Reorganization Mineral Solutions
REGULATED PRESS RELEASE

published on 11/06/2024 at 08:05, 15 days 5 hours ago

Imerys-press-release-TalcUS-06-11-2024-VENG
Imerys provides update on US talc-related litigation, approval of Plan of Reorganization by Bankruptcy Court, and financial impact considerations

Financial Impact Litigation Imerys Bankruptcy Court Plan Of Reorganization
BRIEF

published on 10/30/2024 at 17:50, 21 days 20 hours ago

Imerys Reports Strong Nine-Month Performance in 2024

EBITDA Guidance Revenue Analysis Net Income Growth Imerys Performance European Market Challenges
REGULATED PRESS RELEASE

published on 10/30/2024 at 17:45, 21 days 20 hours ago

Imerys-press-release-Q3-2024-results-30-October-2024-VENG
Imerys delivers solid performance in first nine months 2024 with adjusted EBITDA guidance confirmed. Key highlights: revenue growth, improved profitability, and CEO's comments on market dynamics

Adjusted EBITDA Revenue Growth Performance CEO Imerys
BRIEF

published on 10/15/2024 at 17:50, 1 month 5 days ago

Publication of Imerys voting rights and share capital as of September 30, 2024

Share Capital Voting Rights Sustainable Energy Imerys Mineral Specialties
BRIEF

published on 10/15/2024 at 17:50, 1 month 5 days ago

IMERYS' Share Capital and Voting Rights Update

Share Capital Voting Rights Imerys 2024 Update French Regulation
REGULATED PRESS RELEASE

published on 10/15/2024 at 17:45, 1 month 5 days ago

imerys-15-October-2024-information-share-capital-and-voting-rights-as-of-30-September-2024
Imerys releases number of outstanding shares and voting rights as of 30 September 2024 in compliance with French regulations. The company is a global leader in mineral-based specialty solutions for various industries

Voting Rights French Regulations Outstanding Shares Imerys Mineral-Based Solutions
BRIEF

published on 09/26/2024 at 17:52, 1 month 24 days ago

Imerys Announces Share Capital and Voting Rights as of August 31, 2024

Share Capital Voting Rights Financial Disclosure Imerys August 2024

1 2 ... 7

Accesswire

Published on 11/21/2024 at 13:30, 27 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 27 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 57 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 57 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 57 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 42 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 22 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 42 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 51 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 57 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 59 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 37 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 12 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 12 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE